 
										


1. 4-(2-chloro-4-methoxy-5-methylphenyl)-n-((1s)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl)-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine
2. Nbi 74788
3. Nbi-74788
1. Ssr 125543
2. Ssr125543
3. Ssr-125543
4. 752253-39-7
5. Nbi-74788
6. Crinecerfont [usan]
7. 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1s)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine
8. Mft24bx55i
9. 06-rori
10. Chembl291657
11. Chebi:34969
12. Ssr125543a
13. 752253-39-7 (free Base)
14. Chembl1628268
15. (s)-4-(2-chloro-4-methoxy-5-methylphenyl)-n-(2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl)-5-methyl-n-(prop-2-yn-1-yl)thiazol-2-amine
16. Sr-125543a
17. Crinecerfont [inn]
18. Unii-mft24bx55i
19. Gtpl3533
20. Schembl5453205
21. Dtxsid10996687
22. Ssr-125543a
23. Zinc1550164
24. Bdbm50144192
25. Bdbm50348828
26. Pdsp1_000883
27. Pdsp2_000869
28. Who 10958
29. Ncgc00386642-01
30. Hy-106203
31. Cs-0025238
32. Q27088874
33. [4-(4-bromo-phenyl)-5,6-dimethyl-pyrimidin-2-yl]-dicyclopropylmethyl-propyl-amine
34. 2-thiazolamine, 4-(2-chloro-4-methoxy-5-methylphenyl)-n-((1s)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl)-5-methyl-n-2-propynyl-
35. 2-thiazolamine, 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1s)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-2-propyn-1-yl
36. 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-(prop-2-yn-1-yl)-1,3-thiazol-2-amine
| Molecular Weight | 483.0 g/mol | 
|---|---|
| Molecular Formula | C27H28ClFN2OS | 
| XLogP3 | 8 | 
| Hydrogen Bond Donor Count | 0 | 
| Hydrogen Bond Acceptor Count | 5 | 
| Rotatable Bond Count | 8 | 
| Exact Mass | 482.1594906 g/mol | 
| Monoisotopic Mass | 482.1594906 g/mol | 
| Topological Polar Surface Area | 53.6 Ų | 
| Heavy Atom Count | 33 | 
| Formal Charge | 0 | 
| Complexity | 699 | 
| Isotope Atom Count | 0 | 
| Defined Atom Stereocenter Count | 1 | 
| Undefined Atom Stereocenter Count | 0 | 
| Defined Bond Stereocenter Count | 0 | 
| Undefined Bond Stereocenter Count | 0 | 
| Covalently Bonded Unit Count | 1 | 
Treatment of atypical haemolytic uremic syndrome, Treatment of paroxysmal nocturnal haemoglobinuria
Treatment of congenital adrenal hyperplasia